Pranaya Parenterals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -47.18%
(FY 2022)
- Profit 39.30%
(FY 2022)
- Ebitda 57.19%
(FY 2022)
- Net Worth 69.06%
(FY 2022)
- Total Assets 673.54%
(FY 2022)
About Pranaya Parenterals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kanigiri Gade and Sanagala Reddy serve as directors at the Company.
- CIN/LLPIN
U24304TG2020PTC141379
- Company No.
141379
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2020
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pranaya Parenterals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanigiri Gade  | Director | 04-Jul-2020 | Current |
| Sanagala Reddy | Director | 04-Jul-2020 | Current |
Financial Performance of Pranaya Parenterals.
Pranaya Parenterals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 47.18% decrease. The company also saw a substantial improvement in profitability, with a 39.3% increase in profit. The company's net worth Soared by an impressive increase of 69.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pranaya Parenterals?
Unlock access to Pranaya Parenterals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Pranaya Pharmaceuticals Private LimitedActive 4 years 9 monthsKanigiri Gade and Sanagala Reddy are mutual person
Safe Pharmaceuticals Pvt LtdActive 42 years 9 monthsKanigiri Gade and Sanagala Reddy are mutual person
- Intertech Labs Private LimitedActive 5 years 8 months
Kanigiri Gade and Sanagala Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pranaya Parenterals?
Pranaya Parenterals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pranaya Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pranaya Parenterals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
